濮阳东方医院口碑如何(濮阳东方医院口碑好吗) (今日更新中)

CHICAGO, Jan. 21 (Xinhua) -- Chinese President Hu Jintao, on a trip to the United States, Friday visited an exhibition of companies operating in the U.S. Midwest.Most companies present at the exhibition, which was held in Chicago's suburban city of Woodridge, are Chinese-funded ones.During the visit, Hu encouraged Chinese companies operating in the United States to play a bigger role in promoting economic and trade cooperation between the two countries.Chinese President Hu Jintao visits an exhibition of companies operating in the U.S. Midwest, in Chicago, the United States, Jan. 21, 2011. Most companies present at the exhibition are Chinese-funded ones.The success of Chinese companies in the United States is a specific example of the China-U.S. mutually beneficial cooperation, he added.The operation of these companies not only yields profits for themselves, but adds momentum to economic development in the U.S. Midwest.Hu flew to Chicago after finishing a visit to Washington Thursday afternoon.He will wrap up his four-day state visit to the United States later Friday.

GENEVA, May 17 (Xinhua) -- Health Ministers from Brazil, Russia, India, China and South Africa met here on Tuesday, to prepare for the BRICS Health Ministerial Meeting which is to be held in Beijing on July 11, 2011.The preparatory discussion was convened on the sidelines of the 64th World Health Assembly, which have gathered health authorities from 193 member states of the World Health Organization (WHO).In a press communique following the discussions, the Health Ministers of the BRICS said that the theme of the Beijing meeting would include, promoting innovation and access to affordable medical products, vaccines and other health technologies, in support of reaching the Millennium Development Goals and addressing other public health challenges.Additional agreement decided that the World Conference on Social Determinants of Health will be held in the Brazilian Capital, Rio de Janeiro, next October, as an important opportunity to discuss the inter-linkages between public health and development, as well as exchange experiences in reducing health inequities within and amongst countries.

VIENNA, March 28 (Xinhua) -- Stress hormone is helpful in alleviating acrophobia, a morbid fear of great heights, according to a study by Austrian scientists.They published the findings in the recent Proceedings of the National Academy of Sciences of the United States of America.Frank H. Wilhelm, professor from the Department of Clinical Psychology, Psychotherapy and Health Psychology at the University of Salzburg, Austria, carried out the first study demonstrating the clinical effectiveness of hormones released at periods of high stress in anxiety.The study found hormones and other drugs could be a good addition to behavioral treatment of several anxiety disorders.People with acrophobia have formed a so-called fear memory, which could be activated when the fear-causing stimulus occurs. They tend to react with feelings of extreme fear and anxiety to the ride in a glass elevator.Hence, scientists conducted a confrontation therapy, trying to mask this memory.A total of 40 experimental subjects had been put in a safe environment to constantly confront the fear-inducing stimulus, until they had a new reaction to the perceived threat.Observations also suggested hormones released in high stress had impact on learning and memory.Additionally, stress hormones were believed to facilitate the storage of new, anxiety-free competence and experienced confidence in the therapy. Animal studies have shown that this emotional relearning benefits from cortisol, one of the stress hormones.

WASHINGTON, April 11 (Xinhua) -- Taking a statin before having major elective surgery reduces potentially serious kidney complications, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology.Each year, more than 230 million major elective surgeries are performed around the world. Unfortunately, many patients who undergo major operations develop kidney injury soon after surgery, often due to decreased blood flow to the kidneys and/or the effects of inflammation.Animal studies suggest that the cholesterol-lowering drugs called statins protect the kidneys from such damage, but whether a similar benefit occurs in humans is uncertain. To investigate, Amber Molnar, University of Western Ontario, and colleagues conducted a population-based retrospective study of all older patients who underwent major elective surgery in the province of Ontario, Canada from 1995 to 2008. Surgeries included cardiac, thoracic, vascular, intra-abdominal, and retroperitoneal procedures.A total of 213,347 patients from 211 hospitals underwent major elective surgery, and 4,020 patients (1.9 percent) developed postoperative kidney injury within two weeks of surgery. A total of 1,173 patients (0.5 percent) required dialysis within two weeks of surgery, and 5,974 patients (2.8 percent) died within a month of surgery.Prior to surgery, 67,941 patients (32 percent) were taking a statin. Patients taking a statin were 20 percent less likely to develop kidney injury, need dialysis, and die compared to patients who were not taking a statin. Also, there was evidence of a dose-effect, with patients on higher potency statins having less kidney injury. In addition, statins were beneficial whether they were started greater than 90 days or less than 30 days prior to surgery."Our study suggests that statin use in older persons results in less kidney injury following major elective surgery and reduces the risk of premature death after surgery," said Molnar, adding that the results warrant further investigation with more rigorous studies, but such trials will be difficult to carry out.

来源：资阳报